Revvity
Simon Scrace is an experienced professional in the fields of functional genomics and cell-based assay development, currently serving as Director of Functional Genomics and Cell Panel Screening at Revvity since May 2023. Prior to this role, Simon held various positions at Horizon Discovery from October 2013 to May 2023, including Director of Cell Based Assays and Manager of Functional Genomic Screening. Simon's early career includes a Post Doctoral Researcher role at the University of Oxford, where research focused on signaling pathways in cancer, and previous experience as an Associate Scientist at Vernalis, contributing to structure-based drug design projects. Simon earned a Doctor of Philosophy in Radiobiology from the University of Oxford and a postgraduate diploma in Leadership Practice from The Open University, alongside an MBioChem in Biochemistry from the University of Bath.
This person is not in any teams
This person is not in any offices
Revvity
9 followers
At Revvity, “impossible” is inspiration, and ""can't be done"" is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. With more than $3 billion in revenue and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries. Learn more at www.revvity.com